Mitochondrial localization of P-glycoprotein in the human breast cancer cell line MCF-7/ADM and its functional characterization

31Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The current view of multidrug resisitance is that overexpression of membrane P-glycoprotein (P-gp) is a major causative factor. However, the controversial presence of subcellular P-gp may also participate in the drug resistance. In this study, we sought to investigate the localization and functional characterization of P-gp in mitochondria isolated from MCF-7 and doxorubicin-resistant MCF-7 (MCF-7/ADM) cells. Mitochondria were isolated and purified from the MCF-7 cell line and its resistant cells MCF-7/ADM. We used electron microscopy, western blot analysis and confocal microscopy to demonstrate the localization of P-gp in the mitochondria of MCF-7/ADM cells. Flow cytometry was used to evaluated the efflux function of mitochondrial P-gp in the presence or absence of the P-gp inhibitor cyclosporine A (CsA). Mitochondria were isolated and purified successfully and were analyzed by electron microscopy. Western blotting demonstrated the expression of P-gp in the cell membrane and purified mitochondria from MCF-7/ADM cells but not from sensitive MCF-7 cells. Immunofluorescence analysis using confocal microscopy demonstrated the localization of P-gp [labeled with green fluorescence (FITC)] to the mitochondria [labeled with red fluorescence (Mitotracker Deep Red 633)] of MCF-7/ADM cells and that was absent in MCF-7 cells. Rho123 (a mitochondrial fluorescent probe) accumulation was largely reduced and efflux was strongly increased in the mitochondria of MCF-7/ADM cells compared to those of MCF-7 cells (P<0.01), and these were completely reversed in the presence of the P-gp inhibitor CsA (P<0.01). No significant changes were observed in the mitochondria of MCF-7 cells (P>0.05). P-gp is expressed in the mitochondria of doxorubicin-resistant MCF-7 cells and has an efflux function. It could be involved in multidrug resistance at the subcellular site by pumping out anticancer drugs from mitochondria to protect the function of mitochondria.

References Powered by Scopus

Autophagy: A barrier or an adaptive response to cancer

361Citations
N/AReaders
Get full text

Resistance mechanisms associated with altered intracellular distribution of anticancer agents

346Citations
N/AReaders
Get full text

The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)

192Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Resistance to cancer chemotherapy: Failure in drug response from ADME to P-gp

486Citations
N/AReaders
Get full text

Comparative pharmacology of risperidone and paliperidone

109Citations
N/AReaders
Get full text

Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1

89Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shen, Y., Chu, Y., Yang, Y., & Wang, Z. (2012). Mitochondrial localization of P-glycoprotein in the human breast cancer cell line MCF-7/ADM and its functional characterization. Oncology Reports, 27(5), 1535–1540. https://doi.org/10.3892/or.2012.1671

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

67%

Researcher 4

27%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 6

38%

Biochemistry, Genetics and Molecular Bi... 5

31%

Agricultural and Biological Sciences 4

25%

Nursing and Health Professions 1

6%

Save time finding and organizing research with Mendeley

Sign up for free